Blood pressure was measured using radiotelemetry in chronically instrumented male C57BL6/J mice (Jackson Laboratory).
M icroRNAs (miRNAs) are small (≈18-22 nts) endogenous RNA molecules that act as powerful and versatile regulators of gene expression. They generally act to suppress the expression of mRNAs with a complementary 3′ untranslated region, through translational repression or mRNA degradation. Approximately 2000 miRNAs have been identified in human 1 and predicted to regulate thousands of mRNAs.
Several miRNAs have been shown to regulate gene expression or biological processes relevant to blood pressure regulation or the development of hypertension [2] [3] [4] [5] [6] and it is conceivable that many more miRNAs may be involved. It is, however, challenging to identify these miRNA-target relationships given the promiscuity of miRNA targeting and the uncertainty of target prediction. 7 A single miRNA is capable of regulating several mRNA targets and multiple miRNAs could target the same mRNA.
In this study, we aimed to identify miRNAs that would regulate mRNAs encoded by genes in human endothelial cells related to vascular function and blood pressure regulation. Through knockdown of endogenous miRNAs that were (1) highly expressed in human vascular endothelial cells, and (2) predicted to target mRNA sequences of hypertension-related genes, we have identified 35 miRNA-target pairs in which the endothelial miRNAs tonically reduce the abundance of the target mRNAs that are relevant to blood pressure regulation or hypertension.
Methods
Detailed and additional Methods are available in the online-only Data Supplement.
RNA Analysis
RNA was extracted from human dermal microvascular endothelial cells (HMVEC-D) 8 as previously described 9 or using the Aurum Total RNA 96 Kit (BioRad). Small RNA deep sequencing was performed and data analyzed as previously described. 10 Quantitative polymerase chain reaction analysis was performed using SYBR green chemistry. 9
Inhibition of Endogenous miRNA
HMVEC-D or mice were treated with locked nucleic acid (LNA)modified anti-miRs (Exiqon). 4 
Statistics
A Student t test was used to make comparisons between mRNA expression levels in anti-miR and scrambled oligonucleotide-treated cells. Blood pressure data were analyzed using the Holm-Sidak method for pairwise multiple comparisons. Data are expressed as mean±SE.
Results
The strategy for selecting miRNAs and hypertension-related target genes is described in Figure S1A in the online-only Data Supplement. We first identified miRNAs expressed in human endothelial cells by small RNA deep sequencing analysis of cultured HMVEC-D. A complete list of identified miR-NAs can be found in Table S1 . We detected 212 known human miRNAs in both the replicates. We compiled a list of protein-coding genes that included (1) 29 genes found to be associated with hypertension in human genome-wide association studies (GWASs), 12 ,13 and (2) 28 genes known to be functionally relevant to vascular endothelial cells and the regulation of blood pressure or development of hypertension. Most of the GWAS genes did not have known functional roles in endothelial cells or blood pressure regulation. The second group of genes included genes involved in cortisol processing, sympathetic signaling, vasoconstriction, endothelin signaling, and oxidative stress response. These genes are shown in Table S2 .
We then searched miRNA target prediction databases for mRNAs predicted to be targeted by the 50 most abundant miRNAs detected in HMVEC-D and compared those with the 57 hypertension-related genes shown in Table S2 . We found 30 of the 50 most abundant miRNAs in HMVEC-D were predicted to target at least 1 hypertension-related gene, forming 99 potential miRNA-target pairs. The 99 potential miRNAtarget pairs are shown in Table. To examine whether the predicted targets of the potential miRNA-target pairs were under tonic control by the endogenous miRNAs in HMVEC-D, we used LNA-modified anti-miRs to inhibit each of the 30 miRNAs individually. One would expect the mRNA abundance of a predicted target gene to increase after the anti-miR treatment if the predicted target mRNA is indeed suppressed by the endogenous miRNA via mRNA degradation.
Before initiating the large-scale anti-miR experiment, we tested the efficacy of the anti-miR treatment in endothelial cells in the 96-well format. HMVEC-Ds were transfected with 10 nmol/L LNA anti-miR-29a using Lipofectamine 2000. Effective knockdown of miR-29a was confirmed ( Figure S2) .
The large-scale anti-miR study was performed as outlined in Figure S1B . Briefly, LNA anti-miRs targeting the 30 most abundant miRNAs predicted to target mRNAs of interest from Table were transfected individually into HMVEC-D in triplicate (using 90 wells of a 96-well plate) with control scrambled LNA anti-miR transfected into the remaining 6 wells. This was performed in a total of three 96-well plates. RNA was then extracted using Aurum kit before quantitative reverse transcription polymerase chain reaction analysis of target mRNAs of interest (Table) . Abundance of mRNAs in response to anti-miR treatment was expressed as % change relative to cells treated with scrambled anti-miR for each quantitative polymerase chain reaction run.
The effect of the anti-miR treatment on the abundance of mRNA encoded by hypertension risk genes identified by GWAS is shown in Figure 1 . On the basis of significant increases of mRNA abundance after anti-miR treatment, our data indicate that the abundance of mRNA encoded by the following hypertension GWAS genes were suppressed by endogenous miRNAs in endothelial cells predicted to target them: adrenomedullin (ADM) by miR-26a-5p, miR-92a-3p, miR-92b-3p, miR-181a-5p and miR-181b-5p; plasma membrane calcium-transporting ATPase 1 (ATP2B1) by miR-27a-5p, miR-27b-5p, miR-30a-5p, miR-181a-5p and miR-181b-5p, FURIN by miR-125a-5p; fibroblast growth factor 5 (FGF5) by numerous members of the let-7 family of miRNAs, including let-7a, let-7e, let-7f, and let-7g; Golgi SNAP receptor complex The effects of anti-miR treatment on mRNAs encoded by selected genes involved with sympathetic and endothelial signaling are shown in Figure 2 . Adrenergic receptor A1b (ADRA1B) mRNA was suppressed by endogenous miR-22-3p in endothelial cells, adrenergic receptor A2A (ADRA2A) by miR-30a-5p, adrenergic receptor A2B (ADRA2B) by miR-30e-5p, adrenergic receptor B1 (ADRB1) by let-7b, let-7c, let-7e and let-7g, and endothelin receptor B (EDNRB) by miR-92a-3p and miR-92b-3p.
We also evaluated the potential for highly abundant miR-NAs to target reactive oxygen species and oxidative stressrelated genes in HMVEC-Ds. We found that NADPH oxidase 4 (NOX4) mRNA was suppressed by endogenous miR-92a-3p, miR-92b-3p, miR-99b-5p, and miR-100-5p, whereas catalase (CAT) mRNA and NADPH oxidase 2 (NOX2) mRNA were not significantly suppressed by the miRNAs studied ( Figure 3 ).
Several predicted target mRNAs were paradoxically downregulated after anti-miR treatment (Figures 1-3) , Figure 1 . Effect of anti-miR transfections in human dermal microvascular endothelial cells (HMVEC-D) on the abundance of mRNAs encoded by hypertension risk genes identified by human GWAS. HMVEC-D were transfected with the indicated locked nucleic acid (LNA) anti-miR or scrambled LNA anti-miR (10 nmol/L) for 48 hours. mRNA abundance for predicted targets genes was measured by real-time reverse transcription polymerase chain reaction (PCR) and expressed as % change relative to cells treated with scrambled anti-miR on the same quantitative PCR plate. ADM indicates adrenomedullin; ATP2B1, plasma membrane calcium-transporting ATPase 1; FGF5, fibroblast growth factor 5; GOSR2, Golgi SNAP receptor complex member 2; JAG1, jagged 1; PLECKHA7, pleckstrin homology domain containing, family A member 7; SH2B3, SH2B adapter protein 3; TBX3, T-box 3; and TBX5, T-Box 5; n=3-9. *P<0.05 vs scrambled anti-miR. In total, our data indicate that, of the 95 predicted miRNA-target pairs tested, suppression of the endogenous miRNAs in HMVEC-D resulted in upregulation of target Figure 2 . Effect of anti-miR transfections in human dermal microvascular endothelial cells (HMVEC-D) on the abundance of mRNAs encoded by endothelial signaling genes relevant to hypertension. HMVEC-D were transfected with the indicated locked nucleic acid (LNA) anti-miR or scrambled LNA anti-miR (10 nmol/L) for 48 hours. mRNA abundance of predicted targets was measured by real-time reverse transcription polymerase chain reaction (PCR) and expressed as % change relative to cells treated with scrambled anti-miR on the same quantitative PCR plate. ADRA1B indicates adrenergic receptor A1B; ADRA1D, adrenergic receptor AID; ADRA2A, adrenergic receptor A2A; ADRA2B, adrenergic receptor A2B; ADRB1, adrenergic receptor B1; EDNRA, endothelin receptor A; EDNRB, endothelin receptor B; and EDN1, endothelin 1; n=5-9. *P<0.05 vs scrambled anti-miR. To evaluate the functional relevance of miRNAs identified in the screening portion of the study in hypertensionrelated processes, we performed additional studies using in vivo and in vitro models. We tested whether endogenous miR-21-5p could affect blood pressure of C57BL/6J mice. Intraperitoneal administration of LNA anti-miR-21 induced a transient increase of blood pressure in mice fed a 0.4% NaCl diet compared with mice receiving an LNA-scrambled anti-miR ( Figure 5 ). A second injection of anti-miR was given 9 days later. Blood pressure did not change on the day after the second injection when the mice were still on the 0.4% NaCl diet but decreased significantly after the mice were switched to a 4% NaCl diet and remained decreased to the end of the experiment ( Figure 5 ). Heart rate increased transiently.
We also tested whether the miRNAs we found to target NOX4 mRNA would affect H 2 O 2 levels. The release of H 2 O 2 from HMVEC-D was significantly increased after the cells were transfected with anti-miRs for miR-92a-3p, miR-92b-3p, miR-99-5p, and miR-100-5p when compared with cells transfected with scrambled anti-miR controls ( Figure 6 ).
Discussion
Only a few miRNAs and miRNA-target pairs have been shown to be involved in hypertension or physiological processes related to blood pressure regulation. Expression of the miR-143/145 gene cluster has been shown to be important in facilitating smooth muscle contractility. 2 miR-29 plays an important role in regulating extracellular matrix in the kidneys in a rat model of salt-induced hypertension and renal injury. 3 miR-192 targets Na + /K + -ATPase β 1 and is involved in regulating urine volume in mice fed a high-salt diet. 4 miR-181a and miR-663 were found to target renin, apoptosis-inducing factor mitochondrion-associated 1 and apolipoprotein E mRNAs. 5, 14 11β-hydroxysteroid dehydrogenase type 2 may also be targeted by several miRNAs. 6 This study has substantially expanded this list by identifying 35 miRNA-target pairs, in which mRNA encoded by Of the 35 miRNA-target pairs we identified, 20 pairs involve mRNA encoded by hypertension risk genes nominated by human GWAS. Fibroblast growth factor signaling has been shown to be important for maintaining let-7 levels in endothelial cells. 15 FGF5 has been shown to stimulate angiogenesis of human umbilical vein endothelial cells. 16 The let-7 miRNA family is predicted to target mRNAs encoded by numerous angiogenic genes in addition to FGF5. 17 Adrenomedullin is a proangiogenic and vasodilatory substance, which acts to reduce blood pressure. Several proteins, including adrenomedullin (Adm) and endothelin-1 (ET-1), are known substrates of Furin in the endothelium. 18 The functional relevance to hypertension or endothelial cells remains unknown for the other GWAS gene we analyzed. We found anti-miR-21 treatment reduced mean arterial pressure in mice fed a 4% NaCl diet, suggesting that endogenous miR-21 may affect blood pressure response to salt intake. It remains to be determined whether this effect of miR-21 is mediated by the targeting of JAG1 mRNA identified in this study and what underlies the transient increase of blood pressure in mice on the 0.4% NaCl diet.
Endothelin-1 (EDN1) has been previously shown to be regulated by miR-125a/b in endothelial cells. 19 EDN1 mRNA was not regulated by any of the miRNAs we tested based on our anti-miR experiment. NADPH oxidase 4 (NOX4) is an oxidoreductase that catalyzes the conversion of oxygen to different reactive oxygen species and could affect endothelial cell biology and blood pressure. [20] [21] [22] We found that endogenous miR-92a-3p, miR-92b-3p, miR-99-5p, and miR-100-5p reduced NOX4 mRNA abundance in HMVEC-D and reduced H 2 O 2 release. We examined several other genes involved in the regulation of reactive oxygen species (Table S2) . Their mRNA transcripts were either not predicted targets of abundant miRNAs in HMVEC-D, or their predicted regulation by abundant miRNAs was not supported by results of the anti-miR experiment.
This study took a new approach to identify functionally important miRNAs by nominating nearly 100 miRNA-target pairs potentially relevant to hypertension and testing each of them in HMVEC-D. We used anti-miR treatments, which allowed us to assess the effect of endogenous miRNAs at their native levels of abundance and how partial, physiologically relevant reductions of specific endogenous miRNAs might lead to changes in the abundance of hypertension-related genes. Anti-miR was used to inhibit 30 miRNAs individually, making our study one of the largest studies using miRNA inhibition.
The study is not, however, a comprehensive evaluation of all miRNA-mRNA interactions that would be relevant to hypertension. Instead, we developed a largely unbiased strategy to identify some of the most promising candidate pairs and tested them. We focused on abundant miRNAs. It is possible that the less abundant miRNAs also play an important role in the regulation of hypertension-related genes. The absence or low abundance of certain miRNAs might be important in allowing certain hypertension-related genes to be expressed, and upregulation of these miRNAs might inhibit the expression of hypertension-related genes. We used mRNA abundance as an index of miRNA effect. 23 Several studies have shown that miRNA-target interactions can also involve translational repression, leaving mRNA levels unaffected.
Perspectives
The findings of this study substantially increased the number of experimentally supported miRNA-target pairs with relevance to hypertension from a few to several dozen. The findings indicate widespread, tonic control of mRNAs encoded by hypertension-related genes by endothelial miRNAs and provide a novel and uniquely informative basis for studying the role of miRNAs in hypertension. It would be valuable to identify additional miRNA-target pairs in vascular endothelial cells relevant to hypertension in future studies. It would also be valuable to apply the approach we developed to study additional cell types important in hypertension. Finally, findings of this study can be used as the basis for developing future studies to thoroughly investigate the functional role in hypertension of the miRNA-target pairs identified. 
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None. • 30 miRNAs were subjected to anti-miR inhibition, one of the largest numbers of miRNAs specifically manipulated in a single study.
• The findings increased the number of experimentally supported miRNAtarget pairs with relevance to hypertension from a few to several dozen.
What Is Relevant?
• The findings indicate widespread, tonic control of mRNAs encoded by hypertension-related genes by endothelial microRNAs and provide a novel and uniquely informative basis for studying the role of microRNAs in hypertension.
Supplemental Methods-
Cell culture-Human dermal microvascular endothelial cells (HMVEC-D) were cultured in EGM -MV medium (Clonetics). 1 Cells were subcultured at 80% confluency for propagation.
RNA extraction-RNA for small RNA deep sequencing was extracted using a chloroform/trizol method, as previously described, 2 from cells cultured in 35 mm dishes and collected at >90% confluency. Total RNA was quantified by Nanodrop. The RNA from the transfected cells was extracted from 96 well plates using the Aurum Total RNA 96 Kit (BioRad) and resuspended in RNase-free water. Samples were stored at -80°C until the RNA was analyzed.
Small RNA deep sequencing-Equal amounts of RNA from 6 plates of HMVEC-D cells were pooled, to produce 2 pools (3 plates/pool). Small RNA libraries were created using the TruSeq Small RNA Sample Preparation Kit (Illumina) and cluster generation and sequencing performed using TruSeq PE Cluster Kit v3-cBot-HS, TruSeq SBS kit v3-HS, and a HiSeq 2000 sequencer (Illumina), as previously described. 3 Analysis of small RNA deep sequencing data-Small RNA deep sequencing data was analyzed as previously described, 3 except that sequencing reads were mapped against miRBase v18. miRNA expression levels were normalized using the quartile method. 3 Identification of genes involved with blood pressure regulation and hypertension-The literature was reviewed to identify and compile a list of genes involved in blood pressure regulation and/or hypertension and likely expressed in endothelial cells. Hypertension risk genes identified by human GWAS were obtained from the literature. 4, 5 Inhibition of endogenous miRNA using LNA anti-miR-HMVEC-D cells were subcultured onto 96 well plates and transfected at >90% confluency with locked nucleic acid (LNA)-modified anti-miRs from Exiqon. 6, 7 Transfections of LNA anti-miR at a final concentration of 10 nM were performed using Lipofectamine 2000 (following manufacturer instructions).
Real-time PCR-mRNA expression levels of the blood pressure/hypertension related genes predicted to be targeted by miRNAs inhibited by anti-miR transfection were measured by qPCR using SYBR green chemistry, as previously described. 2 These genes included ADM1, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRB1, ATP2B1, CAT, EDN1, EDNRA, EDNRB, FGF5, FURIN-FES, GOSR2, NOX2, NOX4, PLECKHA7, SH2B3, TBX3, and TBX5. Primer sequences are listed in Supplemental Table S3 .
Chronic Blood Pressure Measurement in anti-miR treated mice-Male C57BL/6J mice (Jackson Lab) were maintained on AIN-76A diet (Dyets) containing 0.4% NaCl after receipt. Telemeters were implanted into the carotid artery at 10 weeks of age, and animals were allowed to recover for 5 days prior to the start of 24 hour blood pressure monitoring. Mice received intraperitoneal injection of LNA-anti-miR-21 or scrambled LNA-anti-miR (Exiqon) (10 mg/kg body weight, in saline) or switched to AIN-76A diet containing 4% NaCl as explained in Results.
Measurement of hydrogen peroxide (H 2 O 2 ) release-HMVEC-D were cultured and transfected with LNA-anti-miR as described above. At 48 hours after transfection an Amplex Red Assay (Life Technologies) was performed to measure the H 2 O 2 released from the cells over a 5.5 hour period. H 2 O 2 signal was normalized by total protein in each well to account for cell number. -2904  maturehomolog_un  0  0  bta-miR-2957  maturehomolog_un  0  0  bta-miR-3578  maturehomolog_un  0  0  bta-miR-3596  maturehomolog_un  40,107  41,745  bta-miR-3600  maturehomolog_un  1,129, 
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